DrugsTreatingRheumatism培训课件.pptVIP

(2) Systemic lupus erythematosus (SLE) (2) Systemic lupus erythematosus (SLE) Pharmacological management The main advances in the past decade in the conventional management of SLE have included studies showing efficacy for mycophenolate as an induction agent for lupus nephritis and the equivalent efficacy of low-dose cyclophosphamide given every 2 weeks in comparison with the preceding National Institutes of Health protocol. Many other immunosuppressives, such as methotrexate, cyclosporin, and leflunomide, are used as steroid-sparing agents to treat SLE and the other autoimmune rheumatic